EnzymeRx, LLC Company Profile
EnzymeRx, LLC is a private, clinical stage biotechnology company developing enzyme-based therapeutics. Our lead product pegsitacase is in phase 1 clinical studies and being developed for the treatment of refractory gout, treatment and prophylaxis of tumor lysis syndrome, and other indications, and we are actively building our preclinical pipeline. For more information about EnzymeRx, uricase, gout or tumor lysis syndrome, please visit www.enzymerx.com.
News Articles
None
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
EnzymeRx, LLC is a private, clinical stage biotechnology company developing enzyme-based therapeutics. Our lead product pegsitacase is in phase 1 clinical studies and being develo...
Gout & Uric Acid Education Society
Formed in September 2005, the Gout & Uric Acid Education Society has a comprehensive educational brochure, as well as a user-friendly Web site for patients, caregivers, family members and healthcare p...
More Information about "EnzymeRx, LLC" on BioPortfolio
We have published hundreds of EnzymeRx, LLC news stories on BioPortfolio along with dozens of EnzymeRx, LLC Clinical Trials and PubMed Articles about EnzymeRx, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EnzymeRx, LLC Companies in our database. You can also find out about relevant EnzymeRx, LLC Drugs and Medications on this site too.
